Overall Score

Capital Allocation

Balance sheet remains very conservative with a current ratio of 9.16x and debt-to-equity of 0.03x.

Cash generation is still weak, with negative operating cash flow and free cash flow TTM despite a cash balance of $5.84/share.

No dividend or buyback support is evident in the current metrics.

Operational Execution

Gross margin remains exceptionally high at 98.7%, indicating strong product economics.

However, profitability is still deeply negative, with operating margin at -265.6% and net margin at -244.7%.

Working capital efficiency remains poor, with days sales outstanding at 212.1 days.

Management Quality

Management is operating with a strong liquidity cushion, which reduces near-term financial risk.

The company is still not translating revenue into earnings or cash flow, suggesting execution remains uneven.

High R&D intensity at 102.1% of revenue indicates continued investment, but it has not yet produced positive returns.